Intake & consent

This notice describes how your medical information may be used and disclosed, and how you can get access to it. Please review it carefully before signing.

Your rights. You may request a copy of your medical record and ask for corrections. You may request confidential communications and place restrictions on certain uses of your information. You may get a list of those with whom your health information has been shared. You may make a complaint if you believe your rights have been violated. You will be notified promptly following a breach of your unsecured health information. You may receive a paper copy of this notice on request.

How we use it. We may use or share your health information for treatment, billing and operational purposes, and as required by law. We will not sell or share your information for marketing purposes without your explicit written authorisation.

1. Nature of the procedure. Intravenous (IV) therapy involves the insertion of a small catheter into a peripheral vein, typically in the hand or forearm, through which fluids, vitamins, minerals, electrolytes, amino acids, medications and/or other compounded substances are administered directly into the bloodstream. The procedure bypasses the gastrointestinal system, resulting in near 100% bioavailability of all administered substances.

2. Potential benefits. Rapid restoration of fluid and electrolyte balance; enhanced delivery of vitamins and minerals with immediate cellular uptake; accelerated recovery from illness, dehydration or physical exertion; support for immune function, energy production and anti-ageing protocols; and improved absorption compared with oral supplementation.

3. Consent to mobile IV hydration services. I voluntarily request and consent to receive intravenous (“IV”) hydration and, where clinically appropriate and lawfully ordered, vitamins, minerals, medications or other substances from DRIP Mobile IV Hydration (“DRIP”). I understand that IV therapy is a medical service and that treatment may be declined, modified, stopped or referred to another healthcare provider if the treating clinician determines that it is not appropriate or safe for me.

4. Medical disclosure and eligibility. I confirm that I have provided complete and accurate information about my medical history, allergies, medications, supplements, pregnancy status, current symptoms and other information requested by the treating clinician. I agree to immediately disclose any change in my condition before or during treatment. I understand that DRIP may require a medical assessment, vital signs, physician authorisation or other screening before treatment.

5. Risks and possible complications. I understand that IV therapy carries the following potential risks, which have been fully explained to me:

• Infiltration — IV fluid leaks into surrounding tissues, causing local swelling and discomfort or pain.
• Phlebitis — inflammation of the vein, with redness, warmth and pain at the insertion site.
• Haematoma — bruising or blood pooling at the IV site following catheter insertion.
• Infection or sepsis — localised or systemic infection, risk reduced using an aseptic technique.
• Extravasation — leakage of irritating substances into tissue, potentially causing damage.
• Air embolism — introduction of air into the bloodstream; minimised through proper line priming.
• Allergic or anaphylactic reaction — severe hypersensitivity requiring emergency intervention.
• Fluid overload — excessive fluid administration, particularly dangerous in cardiac or renal disease.
• Nerve injury — inadvertent needle contact with nearby nerves, with possible neurological symptoms.

I understand that no medical procedure is risk-free. Possible risks of additives can include, but are not limited to, dizziness or fainting, nausea, headache, electrolyte imbalance, medication or vitamin reactions, and other unforeseen complications. Rare complications may be serious and may require emergency medical treatment or hospitalisation.

6. Compounded substances. Some substances administered during IV therapy, including compounded vitamins, minerals, amino acids, NAD+ and glutathione preparations, have not been individually approved by a drug regulator for intravenous use in elective wellness settings. I understand and accept this disclosure.

7. Pregnancy and contraindications. Certain formulations, including high-dose Vitamin C, chelating agents and some compounded preparations, are contraindicated during pregnancy and breastfeeding. By signing, I confirm that I am not currently pregnant or breastfeeding, or that I have disclosed my status and my supervising provider has reviewed and approved the specific formulation.

8. Alternatives. I understand that alternatives include oral supplementation, intramuscular injection, dietary modification and standard medical care. These have been discussed with me or are available on request.

9. Mobile treatment environment. I understand that treatment may occur at my home, hotel, office or another agreed location rather than in a hospital or emergency department. I agree to provide a reasonably clean, safe and accessible environment for treatment. I understand that mobile IV hydration is not a substitute for emergency care, diagnosis or ongoing treatment by my primary healthcare provider.

10. Emergencies. I understand that if I experience severe symptoms before treatment — including chest pain, severe shortness of breath, loss of consciousness, signs of stroke, severe allergic reaction or another medical emergency — I should seek emergency medical care rather than use a mobile hydration service. If an emergency occurs during treatment, I authorise the treating clinician to provide appropriate emergency assistance and to contact emergency medical services when reasonably necessary.

11. No guarantee of results. I understand that individual responses to IV hydration vary. No guarantee or promise has been made regarding any particular health, wellness, recovery, beauty, energy, immunity or other outcome.

12. Aftercare and client responsibilities. I agree to follow aftercare instructions and to promptly seek medical attention if I develop concerning symptoms after treatment. I understand that I should not rely on IV hydration to delay medically necessary evaluation or treatment.

13. Privacy and communication. I consent to the collection and use of my health and contact information as reasonably necessary to assess, provide and document my care, arrange follow-up, process payment and meet applicable legal or regulatory obligations. Separate written consent will be obtained before using identifiable photographs, testimonials or health information for marketing.

14. Acknowledgement and release. I acknowledge that the nature, purpose, expected benefits, reasonable alternatives and material risks of the proposed treatment have been explained to me and that I have had an opportunity to ask questions. To the fullest extent permitted by applicable law, I accept the ordinary and inherent risks of the treatment that have been disclosed to me. Nothing in this document is intended to waive rights that cannot lawfully be waived, excuse professional negligence, or limit obligations imposed by applicable Jamaican law or professional standards.

15. Right to withdraw consent. I understand that I may refuse or stop treatment at any time before or during the procedure, without penalty or prejudice to my future care. I understand that fees for services already provided or supplies already used may remain payable in accordance with DRIP’s disclosed cancellation and payment policies.

16. Client declaration. By signing below, I confirm that I am at least 18 years old or otherwise legally authorised to consent to this treatment; I have read and understood this document; the information I have provided is accurate to the best of my knowledge; my questions have been answered; and I voluntarily consent to treatment.